These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 25030278)

  • 1. Head and neck: normal variations and benign findings in FDG positron emission tomography/computed tomography imaging.
    Højgaard L; Berthelsen AK; Loft A
    PET Clin; 2014 Apr; 9(2):141-5. PubMed ID: 25030278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Special Techniques in PET/Computed Tomography Imaging for Evaluation of Head and Neck Cancer.
    Kumar R; Mukherjee A; Mittal BR
    PET Clin; 2016 Jan; 11(1):13-20. PubMed ID: 26590440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normal Patterns and Pitfalls of FDG Uptake in the Head and Neck.
    Gray BR; Koontz NA
    Semin Ultrasound CT MR; 2019 Oct; 40(5):367-375. PubMed ID: 31635764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Present and future role of FDG-PET/CT imaging in the management of head and neck carcinoma.
    Kitajima K; Suenaga Y; Sugimura K
    Jpn J Radiol; 2015 Dec; 33(12):776-89. PubMed ID: 26507982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined PET-CT in the head and neck: part 1. Physiologic, altered physiologic, and artifactual FDG uptake.
    Blodgett TM; Fukui MB; Snyderman CH; Branstetter BF; McCook BM; Townsend DW; Meltzer CC
    Radiographics; 2005; 25(4):897-912. PubMed ID: 16009814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (18)F-Fluorodeoxyglucose PET/MR Imaging in Head and Neck Cancer.
    Platzek I
    PET Clin; 2016 Oct; 11(4):375-86. PubMed ID: 27593244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abdomen: normal variations and benign conditions resulting in uptake on FDG-PET/CT.
    Zukotynski K; Kim CK
    PET Clin; 2014 Apr; 9(2):169-83. PubMed ID: 25030280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ¹⁸F-fluorodeoxyglucose-positron emission tomography/computed tomography in malignancies of the thyroid and in head and neck squamous cell carcinoma: a review of the literature.
    Lauridsen JK; Rohde M; Thomassen A
    PET Clin; 2015 Jan; 10(1):75-88. PubMed ID: 25455881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear medicine imaging studies in the diagnosis of head and neck disease.
    Chiang S
    Oral Maxillofac Surg Clin North Am; 2014 May; 26(2):239-45. PubMed ID: 24794268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18F FDG PET/CT and Head and Neck Cancer: Patient Management and Outcomes.
    Sheikhbahaei S; Marcus C; Subramaniam RM
    PET Clin; 2015 Apr; 10(2):125-45. PubMed ID: 25829083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on 18F-fluorodeoxyglucose/positron emission tomography and positron emission tomography/computed tomography imaging of squamous head and neck cancers.
    Menda Y; Graham MM
    Semin Nucl Med; 2005 Oct; 35(4):214-9. PubMed ID: 16150243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical
    Childs L; Thompson A; Jones H; Hameeduddin A; Ghufoor K; Adams A
    Clin Imaging; 2018; 49():136-143. PubMed ID: 29414508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal variations and benign findings in pediatric 18F-FDG-PET/CT.
    Grant FD
    PET Clin; 2014 Apr; 9(2):195-208. PubMed ID: 25030282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
    Schaefferkoetter JD; Carlson ER; Heidel RE
    J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDG-PET/CT in radiation treatment planning of head and neck squamous cell carcinoma.
    Arens AI; Troost EG; Schinagl D; Kaanders JH; Oyen WJ
    Q J Nucl Med Mol Imaging; 2011 Oct; 55(5):521-8. PubMed ID: 22019709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of Multiparametric Positron Emission Tomography/Magnetic Resonance Imaging as a One-Stop Shop for Radiation Therapy Planning for Patients with Head and Neck Cancer.
    Olin AB; Hansen AE; Rasmussen JH; Ladefoged CN; Berthelsen AK; Håkansson K; Vogelius IR; Specht L; Gothelf AB; Kjaer A; Fischer BM; Andersen FL
    Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1329-1338. PubMed ID: 32682955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positron emission tomography/computed tomography imaging of head and neck tumors: an atlas.
    Graham MM; Menda Y
    Semin Nucl Med; 2005 Oct; 35(4):220-52. PubMed ID: 16150244
    [No Abstract]   [Full Text] [Related]  

  • 18. Pelvis: normal variants and benign findings in FDG-PET/CT imaging.
    Kohan A; Avril NE
    PET Clin; 2014 Apr; 9(2):185-93. PubMed ID: 25030281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detailed characterization of the early response of head-neck cancer xenografts to irradiation using (18)F-FDG-PET imaging.
    Huang J; Chunta JL; Amin M; Lee DY; Grills IS; Wong CY; Yan D; Marples B; Martinez AA; Wilson GD
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):485-91. PubMed ID: 22331000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain: normal variations and benign findings in fluorodeoxyglucose-PET/computed tomography imaging.
    Berti V; Mosconi L; Pupi A
    PET Clin; 2014 Apr; 9(2):129-40. PubMed ID: 24772054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.